CymitQuimica logo

CAS 1262133-64-1

:

3'-O-(5'-Deoxy-beta-D-ribofuranosyl) Capecitabine

Description:
3'-O-(5'-Deoxy-beta-D-ribofuranosyl) Capecitabine, with the CAS number 1262133-64-1, is a nucleoside analog that is primarily recognized for its role in cancer therapy. This compound is a derivative of capecitabine, which is an oral prodrug of the chemotherapeutic agent 5-fluorouracil (5-FU). The structure of this substance features a ribofuranosyl moiety, which contributes to its biological activity by mimicking natural nucleosides. Its mechanism of action involves selective targeting of tumor cells, where it is enzymatically converted into 5-FU, leading to the inhibition of DNA synthesis and ultimately inducing apoptosis in rapidly dividing cancer cells. The compound exhibits characteristics typical of nucleoside analogs, including solubility in aqueous solutions and the ability to penetrate cellular membranes. Its pharmacokinetics and efficacy are influenced by factors such as metabolic activation and the expression of specific enzymes in tumor tissues. Overall, 3'-O-(5'-Deoxy-beta-D-ribofuranosyl) Capecitabine represents a significant advancement in targeted cancer therapies.
Formula:C20H30FN3O9
Synonyms:
  • pentyl N-[1-[(2R,3S,5R)-4-[(2S,3S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]oxy-3-hydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.